*Trademark(s) of General Electric company
PET/CT"Fluoro-deoxy-glucose (FDG) PET is assessed as an accurate tool to monitor viability of cancer. There is now evidence that in manay tumors PET is used for diagnosis, staging, detection of relapse, restaging and follow-up" EANM-ESTRO guidelines
MRI with DCE
For women with dense breast tissue or those at high-risk for breast cancer due to family history, MRI is often recommended to provide additional imaging to improve diagnosis. The use of MRI can help physicians to better analyse abnormalities detected through mammography. The ability to see more clearly with the VIBRANT applications can aid in a quick diagnosis and decisionmaking to prevent unnecessary mastectomies and/or to monitor therapy.
Discovery* NM/CT 670Built on GE’s pioneering legacy in molecular imaging, the Discovery NM/CT 670 leverages our decades of imaging leadership and advanced SPECT and CT technology.The Discovery NM/CT 670 seamlessly integrates the functional images of SPECT with the precise anatomical detail of multislice CT, empowering you to respond with confidence and accuracy in your diagnosis. If a picture’s worth a thousand words, imagine what cutting edge multi slice fusion imagery would be worth.
A true cross-modality oncology reading platform, OncoQuant helps you correlate and compare CT, MR, PET /CT, and 3D X-ray data. It automates workflow from your PACS , facilitating easy comparisons over time and efficient follow-up exams.